390 related articles for article (PubMed ID: 34272702)
1. Prediction of Drug Clearance from Enzyme and Transporter Kinetics.
Kulkarni PR; Youssef AS; Argikar AA
Methods Mol Biol; 2021; 2342():369-417. PubMed ID: 34272702
[TBL] [Abstract][Full Text] [Related]
2. A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic Modeling.
Andrews-Morger A; Reutlinger M; Parrott N; Olivares-Morales A
Mol Pharm; 2023 Oct; 20(10):5052-5065. PubMed ID: 37713584
[TBL] [Abstract][Full Text] [Related]
3. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
4. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
Manevski N; Umehara K; Parrott N
Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687
[TBL] [Abstract][Full Text] [Related]
5. In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species.
Tess DA; Ryu S; Di L
Pharm Res; 2022 Jul; 39(7):1615-1632. PubMed ID: 35257289
[TBL] [Abstract][Full Text] [Related]
6. Physiologically-based Pharmacokinetic (PBPK) Modelling of Transporter Mediated Drug Absorption, Clearance and Drug-drug Interactions.
Taskar KS; Harada I; Alluri RV
Curr Drug Metab; 2021; 22(7):523-531. PubMed ID: 33397250
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Theoretical Basis for In Vitro-In Vivo Extrapolation (IVIVE) in Predicting Drug Metabolic Clearance and Proposing Future Experimental Pathways.
Benet LZ; Sodhi JK
AAPS J; 2020 Sep; 22(5):120. PubMed ID: 32914238
[TBL] [Abstract][Full Text] [Related]
8. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
Poulin P; Haddad S
J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
[TBL] [Abstract][Full Text] [Related]
9. A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept.
Sugiyama Y; Aoki Y
Drug Metab Dispos; 2023 Sep; 51(9):1067-1076. PubMed ID: 37407092
[TBL] [Abstract][Full Text] [Related]
10. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
Poulin P
J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
[TBL] [Abstract][Full Text] [Related]
11. Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling.
Galetin A
Methods Mol Biol; 2014; 1113():255-88. PubMed ID: 24523117
[TBL] [Abstract][Full Text] [Related]
12. The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance.
Keefer CE; Chang G; Di L; Woody NA; Tess DA; Osgood SM; Kapinos B; Racich J; Carlo AA; Balesano A; Ferguson N; Orozco C; Zueva L; Luo L
Mol Pharm; 2023 Nov; 20(11):5616-5630. PubMed ID: 37812508
[TBL] [Abstract][Full Text] [Related]
13. A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Mediated Mechanisms Using Suspended Human Hepatocytes.
Riccardi KA; Tess DA; Lin J; Patel R; Ryu S; Atkinson K; Di L; Li R
Drug Metab Dispos; 2019 May; 47(5):484-492. PubMed ID: 30787098
[TBL] [Abstract][Full Text] [Related]
14. Can In Vitro-In Vivo Extrapolation Be Successful? Recognizing the Incorrect Clearance Assumptions.
Benet LZ; Sodhi JK
Clin Pharmacol Ther; 2022 May; 111(5):1022-1035. PubMed ID: 34731496
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance.
Liang X; Lai Y
Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):869-886. PubMed ID: 33793347
[No Abstract] [Full Text] [Related]
16. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
Francis LJ; Houston JB; Hallifax D
Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
[TBL] [Abstract][Full Text] [Related]
17. In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.
Poulin P; Kenny JR; Hop CE; Haddad S
J Pharm Sci; 2012 Feb; 101(2):838-51. PubMed ID: 22009717
[TBL] [Abstract][Full Text] [Related]
18. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.
Scotcher D; Jones C; Posada M; Rostami-Hodjegan A; Galetin A
AAPS J; 2016 Sep; 18(5):1067-1081. PubMed ID: 27365096
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
[TBL] [Abstract][Full Text] [Related]
20. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
